Welcome to our dedicated page for Unitedhealth Gp SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding UnitedHealth Group’s layered insurance premiums, Optum analytics, and shifting medical cost ratios across hundreds of pages can drain even seasoned analysts. Need UnitedHealth Group insider trading Form 4 transactions before policy changes hit the headlines, or a quick view of the UnitedHealth Group quarterly earnings report 10-Q filing without combing through EDGAR? Stock Titan eliminates the paperwork burden.
Our AI engine reads every disclosure the moment it posts, turning dense text into plain English highlights. You’ll see UnitedHealth Group Form 4 insider transactions real-time, get UnitedHealth Group SEC filings explained simply, and access understanding UnitedHealth Group SEC documents with AI cards that surface what drives margin shifts, membership growth, and Optum revenue. Whether you’re tracking an UnitedHealth Group 8-K material events explained alert or comparing Rx benefit trends across quarters, the platform keeps all angles covered.
Investors rely on these insights to spot reimbursement risks, follow capital deployment, and gauge management incentives. The site connects each filing type to questions you actually ask:
- UnitedHealth Group annual report 10-K simplified � risk factors, medical cost ratio trends, Optum profitability.
- UnitedHealth Group earnings report filing analysis � quarter-over-quarter membership shifts and cash flow.
- UnitedHealth Group proxy statement executive compensation � incentive structures tied to quality outcomes.
With real-time updates, expert tagging, and AI-powered summaries, Stock Titan turns every disclosure into actionable clarity—so you can move from reading to decision-making faster.
UnitedHealth Group Inc. (UNH) � Form 4 filing dated 26-Jun-2025
Director John H. Noseworthy reported the automatic acquisition of 42 shares of common stock on 24-Jun-2025. The shares represent dividend equivalents on previously vested deferred stock units and were credited at a transaction price of $0.00. Following this routine credit, Noseworthy’s direct ownership rises to 6,105 shares. No derivative transactions or dispositions were reported, and the filing indicates the transaction was not executed under a Rule 10b5-1 trading plan. The small share count and zero-cost basis signal an administrative, non-market purchase with limited impact on public float or insider sentiment.
UnitedHealth Group director Paul R. Garcia reported insider trading activity on June 24, 2025. The transaction involved the acquisition of 11 shares of Common Stock as dividend equivalents paid on vested deferred stock units, received at $0 price.
Following the transaction, Garcia's beneficial ownership consists of:
- 2,481 shares held directly
- 2,146 shares held indirectly through a Revocable Trust
- 45 shares held indirectly through Trust 2
- 55 shares held indirectly through Trust 3
The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units. The Form 4 was filed by attorney-in-fact Faraz A. Choudhry on June 26, 2025.
UnitedHealth Group Inc. (UNH) filed a Form 4 reporting a routine ownership update for Christopher R. Zaetta, EVP & Chief Legal Officer. On 06/24/2025, Zaetta acquired 48.038 common shares at a stated price of $0, representing dividend-equivalent units credited on outstanding restricted stock units (RSUs). These dividend equivalents carry the same vesting conditions as the underlying RSUs and are forfeited if those units fail to vest. Following the credit, Zaetta’s direct beneficial ownership stands at 10,240.746 shares. No derivatives were reported, and there were no dispositions of shares.
UnitedHealth Group Inc. (UNH) � Form 4 filing, 26 Jun 2025: President & CFO John F. Rex reported an automatic acquisition of 131.931 common shares on 24 Jun 2025. The shares represent dividend-equivalent units credited on outstanding restricted stock units; no cash outlay was made (price = $0).
Following the credit, Rex directly owns 203,898.467 shares and indirectly owns 6,791 shares via a trust. No derivative transactions, open-market purchases, or sales were disclosed. The filing is routine and does not reflect a discretionary investment decision.
UnitedHealth Group Inc. (UNH) filed a Form 4 on 26-Jun-2025 detailing a minor insider transaction by Timothy J. Noel, Chief Executive Officer of UnitedHealthcare (a principal subsidiary).
On 24-Jun-2025, Noel acquired 47.823 shares of UNH common stock at $0.00 per share. The acquisition represents dividend-equivalent units automatically credited on outstanding restricted stock units (RSUs); these units carry the same vesting schedule as the underlying RSUs and will be forfeited if the RSUs do not vest. Following the credit, Noel’s direct beneficial ownership increased to 9,243.999 shares.
No open-market purchases, option exercises, or cash transactions occurred, and there was no use of a Rule 10b5-1 trading plan. The filing is procedural in nature, recording routine dividend accruals rather than an active investment decision by the insider.
UnitedHealth Group (UNH) � Form 4 insider transaction
Director Timothy P. Flynn reported the acquisition of 66 common shares on 06/24/2025. The shares represent dividend equivalents paid on previously vested deferred stock units and were received at $0 cost. After this transaction, Flynn’s holdings stand at 9,189 shares held directly and 6,033 shares held indirectly through a trust. The filing was submitted on 06/26/2025 by attorney-in-fact Faraz A. Choudhry.
UnitedHealth Group Inc. (UNH) Form 4 filing overview: Director Frederick William McNabb III reported the automatic acquisition of 53 shares of UnitedHealth common stock on 06/24/2025. The shares represent dividend-equivalent units paid on previously vested deferred stock units and were acquired at a stated price of $0.00 under the company’s equity plan.
Following the transaction, McNabb’s direct beneficial ownership increased to 13,709 shares. No derivative securities were bought or sold, and there were no dispositions. The filing was signed by attorney-in-fact Faraz A. Choudhry on 06/26/2025.
The transaction is routine, carries no cash outlay, and does not reflect an open-market purchase. It modestly increases the director’s equity alignment but is immaterial relative to UnitedHealth’s share count and market capitalization.
On 17 June 2025, UnitedHealth Group (UNH) executed an Underwriting and Pricing Agreement with BofA Securities, Barclays, Citigroup and J.P. Morgan to issue $3.0 billion of SEC-registered senior unsecured notes across four tranches: (i) $500 million 4.400% notes due 2028, (ii) $750 million 4.650% notes due 2031, (iii) $1.0 billion 5.300% notes due 2035 and (iv) $750 million 5.950% notes due 2055. The notes settled on 20 June 2025 under the company’s 2008 indenture with U.S. Bank Trust Company as trustee and were issued from automatic shelf registration statement 333-270279.
The 8-K is limited to filing transaction documents: underwriting & pricing agreements (Ex. 1.1-1.2), officers� certificates & forms of notes (Ex. 4.1-4.4) and the Hogan Lovells legality opinion (Ex. 5.1). No changes to earnings guidance or strategy are disclosed. Proceeds are earmarked for general corporate purposes, providing additional liquidity while modestly increasing leverage and interest expense. By locking in fixed coupons out to 2055, UNH further staggers its maturity ladder at rates consistent with its large-cap investment-grade credit profile.
FAQ
What is the current stock price of Unitedhealth Gp (UNH)?
What is the market cap of Unitedhealth Gp (UNH)?
